Ellen Christine Fye, MA, CCC-SLP | |
1321 Leslie Ave, Alexandria, VA 22301-1616 | |
(703) 548-6912 | |
Not Available |
Full Name | Ellen Christine Fye |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 1321 Leslie Ave, Alexandria, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750782835 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 2202007109 (Virginia) | Primary |
235Z00000X | Speech-language Pathologist | 02732 (Maryland) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Ellen Christine Fye, MA, CCC-SLP 1321 Leslie Ave, Alexandria, VA 22301-1616 Ph: (703) 548-6912 | Ellen Christine Fye, MA, CCC-SLP 1321 Leslie Ave, Alexandria, VA 22301-1616 Ph: (703) 548-6912 |
News Archive
"In a decisive victory for India's pharmaceutical industry, India's Supreme Court rejected Novartis' patent application for the cancer drug Glivec on Monday, ending a seven-year battle by the Swiss drug maker to get a patent in India on its powerful leukemia drug," Time reports (Mahr, 4/1).
Chlamydia is the most prevalent bacterial sexually transmitted infection (STI) in the world. There is no vaccine to prevent infection. However, researchers from the University of North Carolina at Chapel Hill, in partnership with colleagues at other sites in the US, Europe and Australia, will receive up to $10.7 million over five years from the National Institutes of Health (NIH) to move closer to identifying a vaccine candidate.
Studies of breast cancer risk and treatment outcomes are not taking sufficient account of race/ethnicity, economic status, education level, health insurance status and other social factors, according to scientists at Johns Hopkins Bloomberg School of Public Health.
Ligand Pharmaceuticals Incorporated today announced that pursuant to an amendment to a March 2006 research agreement with GlaxoSmithKline, GSK has agreed to accelerate the timing of a $500,000 payment to Ligand that would otherwise have been required upon the identification of a new lead chemical series for advancement in its alliance with GSK.
› Verified 1 days ago
Tammy L Pilgrim, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1510 Collingwood Rd, Alexandria, VA 22308 Phone: 703-765-6107 | |
Nicole Ann Ladia, M.S.ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6116 Bangor Dr, Alexandria, VA 22303 Phone: 571-239-3688 | |
Ms. Shunnae A Baker, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1340 Braddock Pl, Alexandria, VA 22314 Phone: 510-432-7301 | |
Despina Timbinaris, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5236 Ballycastle Cir, Alexandria, VA 22315 Phone: 571-344-0792 | |
Fabiola Santos, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1340 Braddock Pl, Alexandria, VA 22314 Phone: 703-619-8000 | |
Beth Blake Harrison, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5708 Callcott Way Unit A, Alexandria, VA 22312 Phone: 703-678-5692 | |
Danielle Hyde, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8111 Tis Well Dr, Alexandria, VA 22306 Phone: 814-218-4029 |